Japanese evidence on Janus kinase inhibitors for rheumatoid arthritis: a narrative review of risk-optimized use.

Matsumoto H, Yoshida S, Tahara M, Nibu H, Yamamoto S, Sakamoto T, Ogawa S, Saito K, Sumichika Y, Suzuki E, Asano T, Sato S, Shimojima Y

Open source

DOI: 10.3389/fphar.2026.1842268
Published: 2026
Container: Frontiers in pharmacology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1842268,
  title = {Japanese evidence on Janus kinase inhibitors for rheumatoid arthritis: a narrative review of risk-optimized use.},
  author = {Matsumoto H and Yoshida S and Tahara M and Nibu H and Yamamoto S and Sakamoto T and Ogawa S and Saito K and Sumichika Y and Suzuki E and Asano T and Sato S and Shimojima Y},
  year = {2026},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2026.1842268},
  url = {https://doi.org/10.3389/fphar.2026.1842268}
}

RIS

TY  - JOUR
TI  - Japanese evidence on Janus kinase inhibitors for rheumatoid arthritis: a narrative review of risk-optimized use.
AU  - Matsumoto H
AU  - Yoshida S
AU  - Tahara M
AU  - Nibu H
AU  - Yamamoto S
AU  - Sakamoto T
AU  - Ogawa S
AU  - Saito K
AU  - Sumichika Y
AU  - Suzuki E
AU  - Asano T
AU  - Sato S
AU  - Shimojima Y
PY  - 2026
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2026.1842268
UR  - https://doi.org/10.3389/fphar.2026.1842268
ER  -

APA

H, M., S, Y., M, T., H, N., S, Y., T, S., S, O., K, S., Y, S., E, S., T, A., S, S., & Y, S. (2026). Japanese evidence on Janus kinase inhibitors for rheumatoid arthritis: a narrative review of risk-optimized use.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2026.1842268

Source records

pubmed · retrieved 2026-09-26T08:48:30.677Z